Crohn's Disease (Regional Enteritis) Global Clinical Trials Review, H1, 2019

GlobalData's clinical trial report, “Crohn's Disease (Regional Enteritis) Global Clinical Trials Review, H1, 2019" provides an overview of Crohn's Disease (Regional Enteritis) clinical trials scenario. This report provides top line data relating to the clinical trials on Crohn's Disease (Regional Enteritis). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies mentioned

AbbVie Inc

Takeda Pharmaceutical Co Ltd

Johnson & Johnson

UCB SA

Pfizer Inc

Bristol-Myers Squibb Co

Merck & Co Inc

C. H. Boehringer Sohn AG ...

AbbVie Inc

Takeda Pharmaceutical Co Ltd

Johnson & Johnson

UCB SA

Pfizer Inc

Bristol-Myers Squibb Co

Merck & Co Inc

C. H. Boehringer Sohn AG & Co KG

Abbott Laboratories

IQVIA Holdings Inc

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Report Guidance 6

GlobalData Clinical Trials Report Coverage 7

Clinical Trials by Region ...

Table of Contents 2

List of Tables 4

List of Figures 5

Report Guidance 6

GlobalData Clinical Trials Report Coverage 7

Clinical Trials by Region 8

Clinical Trials and Average Enrollment by Country 9

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12

Top Five Countries Contributing to Clinical Trials in Europe 13

Top Countries Contributing to Clinical Trials in North America 14

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15

Top Five Countries Contributing to Clinical Trials in Central and South America 16

Clinical Trials by G7 Countries: Proportion of Crohn's Disease (Regional Enteritis) to Gastrointestinal Clinical Trials 17

Clinical Trials by Phase in G7 Countries 19

Clinical Trials in G7 Countries by Trial Status 20

Clinical Trials by E7 Countries: Proportion of Crohn's Disease (Regional Enteritis) to Gastrointestinal Clinical Trials 22

Clinical Trials by Phase in E7 Countries 24

Clinical Trials in E7 Countries by Trial Status 25

Clinical Trials by Phase 27

In Progress Trials by Phase 28

Clinical Trials by Trial Status 29

Clinical Trials by End Point Status 31

Subjects Recruited Over a Period of Time 32

Clinical Trials by Sponsor Type 33

Prominent Sponsors 34

Top Companies Participating in Crohn's Disease (Regional Enteritis) Therapeutics Clinical Trials 36

Prominent Drugs 38

Latest Clinical Trials News on Crohn's Disease (Regional Enteritis) 39

Apr 15, 2019: MorphoSys announces that its licensee Janssen has expanded clinical development of Guselkumab (Tremfya) into familial adenomatous polyposis 39

Mar 29, 2019: Data published in The Lancet shows that CT-P13 is non-inferior to reference Infliximab in inflammatory bowel disease 39

Mar 08, 2019: Arena Pharmaceuticals presents phase 2 data of Olorinab at the 14th Congress of European Crohn's and Colitis Organisation 40

Mar 08, 2019: Celltrion Healthcare showcases initial data from year-long study for subcutaneous formulation of CT-P13 (biosimilar infliximab) in patients with Crohn's disease 40

Mar 07, 2019: Landos Biopharma to present at upcoming investor conferences 40

Mar 05, 2019: Landos Biopharma Announces Publication of Results from Non-clinical Toxicity Studies Further Characterizing the Safety Profile of BT-11 41

Feb 27, 2019: Immutep to present on its auto-immune diseases drug candidate IMP761 at 14th Congress of ECCO 41

Feb 27, 2019: Janssen Demonstrates strong commitment to advancing science of inflammatory bowel disease with robust selection of data presentations at 14th Congress of ECCO 41

Feb 20, 2019: Koutif Therapeutics announces FDA acceptance of IND application for novel new treatment of IBD 43

Feb 13, 2019: Nash Pharmaceuticals to present data on drug candidate NP-120 at The Digestive Disease Week Annual Conference 43

Feb 13, 2019: Nash Pharmaceuticals to present data on drug candidate NP-178 at The Digestive Disease Week Annual Conference 44

Jan 31, 2019: Cytori Cell Therapy clinical trial results in Crohn’s Disease 44

Clinical Trial Profile Snapshots 45

Appendix 885

Abbreviations 885

Definitions 885

Research Methodology 886

Secondary Research 886

About GlobalData 887

Contact Us 887

Source 888

List of Tables

Crohn's Disease (Regional Enteritis) Therapeutics, Global, Clinical Trials by Region, 2019* 8

Crohn's Disease (Regional Enteritis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top ...

Crohn's Disease (Regional Enteritis) Therapeutics, Global, Clinical Trials by Region, 2019* 8

Crohn's Disease (Regional Enteritis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9

Crohn's Disease (Regional Enteritis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11

Crohn's Disease (Regional Enteritis) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12

Crohn's Disease (Regional Enteritis) Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13

Crohn's Disease (Regional Enteritis) Therapeutics Clinical Trials, North America, Top Countries, 2019* 14

Crohn's Disease (Regional Enteritis) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 15

Crohn's Disease (Regional Enteritis) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 16

Proportion of Crohn's Disease (Regional Enteritis) to Gastrointestinal Clinical Trials, G7 Countries (%), 2019* 17

Crohn's Disease (Regional Enteritis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19

Crohn's Disease (Regional Enteritis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20

Proportion of Crohn's Disease (Regional Enteritis) to Gastrointestinal Clinical Trials, E7 Countries (%), 2019* 22

Crohn's Disease (Regional Enteritis) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 24

Crohn's Disease (Regional Enteritis) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 25

Crohn's Disease (Regional Enteritis) Therapeutics, Global, Clinical Trials by Phase, 2019* 27

Crohn's Disease (Regional Enteritis) Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 28

Crohn's Disease (Regional Enteritis) Therapeutics, Global, Clinical Trials by Trial Status, 2019* 29

Crohn's Disease (Regional Enteritis) Therapeutics Clinical Trials, Global, by End Point Status, 2019* 31

Crohn's Disease (Regional Enteritis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 32

Crohn's Disease (Regional Enteritis) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 33

Crohn's Disease (Regional Enteritis) Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 34

Crohn's Disease (Regional Enteritis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 36

Crohn's Disease (Regional Enteritis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 38

List of Figures

Crohn's Disease (Regional Enteritis) Therapeutics, Global, Clinical Trials by Region (%), 2019* 8

Crohn's Disease (Regional Enteritis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top ...

Crohn's Disease (Regional Enteritis) Therapeutics, Global, Clinical Trials by Region (%), 2019* 8

Crohn's Disease (Regional Enteritis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9

Crohn's Disease (Regional Enteritis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11

Crohn's Disease (Regional Enteritis) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 12

Crohn's Disease (Regional Enteritis) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 13

Crohn's Disease (Regional Enteritis) Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 14

Crohn's Disease (Regional Enteritis) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 15

Crohn's Disease (Regional Enteritis) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 16

Proportion of Crohn's Disease (Regional Enteritis) to Gastrointestinal Clinical Trials, G7 Countries (%), 2019* 17

Crohn's Disease (Regional Enteritis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19

Crohn's Disease (Regional Enteritis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20

Proportion of Crohn's Disease (Regional Enteritis) to Gastrointestinal Clinical Trials, E7 Countries (%), 2019* 22

Crohn's Disease (Regional Enteritis) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 24

Crohn's Disease (Regional Enteritis) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 25

Crohn's Disease (Regional Enteritis) Therapeutics, Global, Clinical Trials by Phase (%), 2019* 27

Crohn's Disease (Regional Enteritis) Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 28

Crohn's Disease (Regional Enteritis) Therapeutics, Global, Clinical Trials by Trial Status, 2019* 29

Crohn's Disease (Regional Enteritis) Therapeutics Clinical Trials, Global, by End Point Status, 2019* 31

Crohn's Disease (Regional Enteritis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 32

Crohn's Disease (Regional Enteritis) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 33

Crohn's Disease (Regional Enteritis) Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 34

Crohn's Disease (Regional Enteritis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 36

Crohn's Disease (Regional Enteritis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 38

GlobalData Methodology 886

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports